德邦科技(688035.SH):控股子公司蘇州泰吉諾自2023年第四季度開始向杭州宇樹科技提供一款熱界面材料
格隆匯5月13日丨德邦科技(688035.SH)在投資者互動平臺表示,公司控股子公司蘇州泰吉諾自2023年第四季度開始向杭州宇樹科技有限公司提供一款熱界面材料,主要應用於CPU芯片散熱,上述業務佔公司整體收入比例很低,短期內對公司整體業績影響還很小。 目前人形機器人領域仍處於發展的初期階段,公司會持續關注人形機器人發展動態,抓住行業發展帶來的新的機遇,相關業務情況,請以公司公告爲準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.